LMNA公司
医学
沙库比林
心脏病学
沙库比林、缬沙坦
内科学
心肌病
缬沙坦
心力衰竭
心源性猝死
射血分数
拉明
核心
精神科
血压
作者
Theresa Maitz,Rahul Gupta,Kathryn Persin,Deborah W Sundlof
出处
期刊:Future Cardiology
[Future Medicine]
日期:2022-06-15
标识
DOI:10.2217/fca-2021-0148
摘要
Arrhythmogenic right ventricular (RV) cardiomyopathy is an autosomal dominant inherited cardiomyopathy that is characterized by an increased risk of ventricular arrhythmias, sudden cardiac death and, less commonly, heart failure. The authors present the case of a 36-year-old woman with familial lamin cardiomyopathy with positive LMNA mutation and genetic testing revealing LMNA and TMEM43 mutations consistent with arrhythmogenic RV cardiomyopathy. The patient presented with clinical signs of RV failure. Transthoracic echocardiogram showed newly reduced RV function in the absence of left ventricular involvement. Cardiac MRI demonstrated diffuse late gadolinium enhancement of the mid-level and apical RV anterior free wall. Diuretics were started, and sacubitril–valsartan was added when the patient's symptoms persisted. Diuretics were then discontinued, and sacubitril–valsartan was the primary therapy. This is the first reported case of symptomatic and imaging-proven RV recovery in a patient with symptomatic RV failure in the setting of arrhythmogenic RV cardiomyopathy treated with sacubitril–valsartan.
科研通智能强力驱动
Strongly Powered by AbleSci AI